Penicillamine: Myasthenia-gravis: case report.

His motor nerve stimulation tests of the facial nerve revealed a >10% decreasing response indicating postsynaptic neuromuscular junction disorder. B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important event A 15-year-old boy developed myasthenia gravis during treatment with penicillamine for wilson's disease. D-penicillamine Induced Myasthenia Gravis in Wilson's Disease: A Case Report. [Extracted from the article]